The changing epidemiology of streptococcus pneumoniae serotype 19A clonal complexes

Journal of Infectious Diseases

Volumn 203, Issue 10, 2011, Pages 1345-1347

  Tyrrell, Gregory J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLONAL VARIATION; DNA SEQUENCE; HOUSEKEEPING GENE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NOTE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 79954985845     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir056     Document Type: Note

References (16)

1. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33:2759-62.
2. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm M. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microb 2007; 45:1225-33. (Pubitemid 46626489)
3. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-54. (Pubitemid 351412007)
4. Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008; 13:pii 18962.
5. Van der Linden M, Imöhl M, Reinert R. Surveillance of IPD in children in Germany 2004-2008, first results of the German national immunization program for PCV7 [abstract G-2110]. In: Program and abstracts of the 48th Interscience Conference on Antimicrobials and Chemotherapy/44th Infectious Diseases Society of America (Washington, DC). 2008. Poster presented at: 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 25-28 October 2008. Abstract G-2110.
6. Vestrheim DF, L voll O, Aaberge IS, et al. Effectiveness of a 211 dose schedule pneumococcal vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008; 26:3277-81.
7. Reinert RR, Jacobs MR, Kaplan SL. Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development. Vaccine 2010; 28:4249-59.
8. Pillai DR, Shahinas D, Buzina A, et al. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009; 10:642-54.
9. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniaeserotype 19A in United States, 2005. J Infec Dis 2008; 197:1016-27. (Pubitemid 351590031)
10. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 1998; 144:3049-60. (Pubitemid 28515583)
11. Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB. Shifting genetic structure of invasive serotype 19A Pneumococci in the United States. J Infect Dis 2011. (in this issue).
12. Gertz RE; Jr, McEllistrem MC, Boxrud DJ, et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 2003; 41:4194-216. (Pubitemid 37099686)
13. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, and the Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005; 192:1988-95. (Pubitemid 41681898)
14. Singleton RJ, Hennesy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92. (Pubitemid 46658647)
15. Beall B, McEllistrem MC, Gertz RE Jr, et al. Pre- and postvaccine clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001 and 2002. J Clin Microb 2006; 44:999-1017.
16. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathogens 2007; 3:e168.